How to Raise the Bar and Overcome Barriers in the Digital Health Space

Market Data Forecast (via Digital Journal) predicts that the size of the global digital therapeutics (DTx) market will grow at a combined annual growth rate of 34.62% between 2022 and 2027 and be worth $14.4 billion by 2027 up from $3.26 billion in 2022. This market includes companies like Omada Health Inc., Welldoc Inc. and Livongo Health, which operate in the chronic disease management market. During 2021, the aforementioned research found that the software segment was the largest revenue generator and expects its revenue to rise dramatically; the patient segment accounted for the most significant share of global revenue (due to patients’ increased use of digital solutions); the diabetic application segment generated the most revenue by application. The research shows that the U.S. DTx market’s growth was boosted by favorable reimbursement rules and the presence of strong competitors.